期刊文献+

miRNA-143-3p与Ki-67在人脑胶质瘤中表达及相关性 被引量:2

下载PDF
导出
摘要 目的探讨miRNA-143-3p与Ki-67在人脑胶质瘤的表达及相关性。方法收集上海中医药大学附属龙华医院神经外科切除后经病理证实的人脑胶质瘤标本120例为研究组,另收集同期因脑外伤获取的正常脑组织标本40例为正常组。采用免疫组化SP法检测miRNA-143-3p、Ki-67在人脑胶质瘤和正常脑组织中的表达水平;采用Spearman秩相关分析miRNA-143-3p、Ki-67在胶质瘤组织中表达水平的相关性。结果正常脑组织中miRNA-143-3p与Ki-67均为阴性表达。高级别胶质瘤中miRNA-143-3p与Ki-67的阳性率均明显高于低级别胶质瘤,差异均有统计学意义(P<0.05)。miRNA-143-3p与Ki-67蛋白在胶质瘤组织中呈正相关(r=0.964,P<0.05)。结论 miRNA-143-3p可有效反映胶质瘤的病变程度,并且miRNA-143-3p与Ki-67联合检测可反映胶质瘤的恶性程度,可能成为胶质瘤生物标记的新指标。
出处 《临床军医杂志》 CAS 2019年第11期1222-1224,共3页 Clinical Journal of Medical Officers
  • 相关文献

参考文献8

二级参考文献107

  • 1曾宪起,申长虹,浦佩玉,杨树源.应用替莫唑胺对照司莫司丁治疗恶性脑胶质瘤的疗效观察[J].中华神经外科杂志,2006,22(4):204-207. 被引量:50
  • 2方木平,刘汉忠,刘永桥.VEGF-C及其受体在皮肤恶性黑素瘤中的表达及其临床意义[J].中国麻风皮肤病杂志,2007,23(5):379-381. 被引量:6
  • 3Osoba D,Brada M,Yung WK.Health-related quality of life in patients treated with temozolomide versus procarbazine for recurrent glioblastoma multiforme [J].J Clin Oncol,2000,18 (8):1481.
  • 4Zunkeler B,Carson RE,Olson J,et al.Quantification and pharmacokinetics of blood-brain disruption in humans [J].J Neurosurgery,1996,85 (7) :1056.
  • 5Weyebrock A,Walbridge S,Pluta RM,et al.Selective opening of the blood-tumor barrier by a nitric oxide donor and long-term survival in rats with C6 gliomas[J].J Neurosurg,2003,99 (4):728.
  • 6Prados MD,ScholdSC JR,Fine HA,et al.A randomized doublebline placebo-controlled phase 2 study of RMP-7 in combination with carboplatin administered intravenously for the treatment of recurrent malignant glioma [J].Neuro Oncol,2003,5 (2):96.
  • 7Brandes AA,Vastola F,Basso U,et al.A prospective study on glioblastoma in the elderly[J].Cancer,2003,97(3):657.
  • 8Brandes AA,Turazzi S,Basso U,et al.A multidrug combination designed for reversing resistance to BCNU in glioblastoma [J].Neurology,2002,58 (12):1759.
  • 9Central Brain Tumor Registry of the United States(CBTRUS).Statistical report:primary brain tumors in the United States,1997-2001.Hinsdale IL[M].Central Brain Tumor Registry of the United States,2004.
  • 10Buckner JC,Gesme D Jr,O,fallon JR,et al.Phase Ⅱ trial of procarbazine,lomustine,and vincristine as initial therapy for patients with low-grade oligodendroglioma or oligoastrocytoma:efficacy and associations with chromosomal abnormalities[J].J Clin Oncol,2003,21(1) :251.

共引文献47

同被引文献31

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部